Value Peer-spectives

In September, Cardinal Health Specialty Solutions announced the launch of a new collaboration initiative with Health Alliance Plan (HAP) and Physician Resource Management to establish an evidence-based clinical pathways program aimed at reducing the costs of cancer care while improving quality of care.

The Institute of Medicine (IOM) recently held a roundtable discussion on the status of genome-based drug development.

The recent discovery of 3 subtypes of high-grade serous ovarian cancer (HGSOC) by researchers at Dana-Farber Cancer Institute will soon enable oncologists to determine which of their patients with HGSOC—the most common type of ovarian cancer—are most likely to benefit from a certain class of drugs.

Quest Diagnostics, the leading provider of diagnostic testing, has introduced a new laboratory test that identifies molecular changes to cervical cells that may signal increased risk for cervical cancer.

Several researchers at the University of Rochester Medical Center have been studying the effects of exercise on patients with cancer for some time now.

Greenville Hospital System (GHS) has launched the Center for Integrative Oncology and Survivorship, which offers emotional services for cancer survivors developed by Cancer Support Community (CSC), an international provider of cancer-related social and emotional services.

Texas Children’s Cancer Center has opened the first center dedicated entirely to the research, care, and treatment of children with lymphoma. The Fayez Sarofim Lymphoma Center at Texas Children’s Cancer Center was made possible by a gift of $10 million to Texas Children’s Hospital.